INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

The gibberellins (GAs) are a group of phytohormones that influence many developmental processes in higher plants, including seed germination, stem elongation, flowering, and fruit set. GAs also are produced by the rice pathogen Gibberella fujikuroi (mating population C) and a few other fungal genera (30), but nothing is known about the role of GAs in fungi. Cultures of G. fujikuroi are used for the commercial production of GAs, particularly gibberellic acid (GA₃), for use in agriculture (26).

The biosynthesis of GAs has been investigated for many years in G. fujikuroi and in higher plants. The terpenoid nature of GAs was first established by the incorporation of [2-¹⁴C]mevalonic acid into GA₃, which is the end product of the fungal pathway (20) (Fig. 1). The biosynthesis follows the isoprenoid pathway to geranylgeranyl diphosphate (GGPP), which, in plants, undergoes a two-step cyclization reaction in which GGPP is converted to ent-kaurene via ent-copalyl diphosphate (CPP) (20). ent-Kaurene is metabolized to GAs by reactions catalyzed by cytochrome P450 monooxygenases and, in plants, 2-oxoglutarate-dependent dioxygenases (11). In G. fujikuroi, GGPP synthase, which catalyzes the formation of GGPP, is encoded by two genes, one of which, ggs2, is specific for GA biosynthesis (31). In contrast to plants, in which cyclization of GGPP is catalyzed by two enzymes, CPP synthase (CPS) and ent-kaurene synthase (KS), in the fungi G. fujikuroi and Phaeosphaeria, both steps are catalyzed by a bifunctional CPS/KS enzyme (17, 32).

View larger version (13K): [in this window] [in a new window]   FIG. 1.   GA biosynthesis pathway in G. fujikuroi. Genes with known functions are indicated. Thick arrows indicate the major pathway and the double arrows represent several steps. 14C-labeled substrates used in metabolism experiments are marked with a *.

Most of the genes of the early isoprenoid pathway have been cloned from G. fujikuroi, including HMG-CoA reductase (36), farnesyl diphosphate synthase (16), and a general GGPP synthase (ggs1) (22). Five genes of the GA pathway in G. fujikuroi, comprising cps/ks, the GA-specific GGPP synthase (ggs2), and three cytochrome P450 monooxygenase genes, were shown to be closely linked in a gene cluster (31). Recently, we showed that one of these three genes, P450-1, catalyzes four oxidation steps in the main pathway from ent-kaurenoic acid to GA₁₄ via GA₁₂-aldehyde (27). In this report, we describe the isolation and functional characterization of a fourth P450 monooxygenase gene which is also located in the GA gene cluster and is closely linked to P450-1 through a shared promoter. Using gene disruption and by expressing P450-4 in the GA-deficient mutant SG139, which lacks the entire gene cluster, we show that the gene codes for a multifunctional ent-kaurene oxidase, catalyzing all three oxidation steps between ent-kaurene and ent-kaurenoic acid. Furthermore, it complements the genetic block in the GA-deficient UV mutant B1-41a, which contains a point mutation in the P450-4 locus.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Fungal strains and culture conditions. G. fujikuroi m567, a wild-type strain from rice, was provided by the Fungal Culture Collection, Weimar, Germany. The wild-type strain IMI 58289 and the GA-defective mutant strain SG139 (3) were provided by E. Cerda-Olmedo and J. Avalos (University of Sevilla, Sevilla, Spain). SG139 has completely lost the GA gene cluster as demonstrated by Southern blotting and PCR analysis. The GA-deficient mutant B1-41a, obtained by UV irradiation of G. fujikuroi strain GF-1a (4), was provided by J. MacMillan (University of Bristol, Bristol, United Kingdom).

Bacterial strains and plasmids. Escherichia coli strain Top10 (Invitrogen, Groningen, The Netherlands) was used for plasmid propagation. Vector pUC19 was used to clone DNA fragments carrying the G. fujikuroi P450-4 gene or parts of it. For gene disruption experiments, a 0.9-kb internal PCR fragment obtained with primers P450-4-GD1 and P450-4-GD2 was cloned into the vector pCR2.1 (Invitrogen). The fragment was excised with XbaI/HindIII and cloned into the vector pAN7-1 (25) carrying the hygromycin B resistance cassette. For gene complementation, a 5.8-kb BamHI fragment carrying the entire P450-4 gene was cloned into pGPC1 (7). P450-4 cDNA clones in the Uni-Zap XR  vector were converted to pBluescript SK() phagemids by in vivo rescue according to the manufacturer's protocol (Stratagene, La Jolla, Calif.). For the identification of the mutation site in the mutant B1-41a, the mutant copy of P450-4 was amplified by PCR and cloned into the PCR cloning vector pCR2.1 for sequence analysis.

Media and culture conditions. For DNA isolation, the fungal strains were grown in 100 ml of CM liquid medium optimized for Fusarium spp. (24) for 3 days at 28°C on a rotary shaker set at 200 rpm. The mycelia were harvested by filtration through a sterile glass filter (G2; Schott, Jena, Germany), washed with sterile distilled water, frozen in liquid nitrogen, and lyophilized for 24 h. The lyophilized mycelial tissue was ground to a fine powder with a mortar and pestle.

Radiolabeled substrates. ent-[1,7,12,18-¹⁴C₄]kaurene (specific radioactivity, 8.25 TBq · mol¹), ent-[¹⁴C₄]kaurenal, ent-[¹⁴C₄]kaurenal, ent-[¹⁴C₄]kaurenoic acid (each 7.47 TBq · mol¹), and [¹⁴C₄]GA₁₂-aldehyde (6.81 TBq · mol¹) were prepared from R-[2-¹⁴C]mevalonic acid using a cell-free system from pumpkin endosperm, as described by Graebe et al. (10). [¹⁴C₄]GA₁₄ (5.58 TBq · mol¹) was prepared from [¹⁴C₄]GA₁₂-aldehyde by incubation with a cell-free system from G. fujikuroi (34). [17-¹⁴C]GA₄ (1.85 TBq · mol¹) was prepared from [17-¹⁴C]GA₉ by incubation with a recombinant sugar beet GA 3-hydroxylase, as described by Williams et al. (35). The [17-¹⁴C]GA₉ was synthesized from GA₉ 17-norketone and [¹⁴C-methyl]triphenylphosphonium bromide essentially as described previously (19).

DNA and RNA isolation. Genomic DNA was isolated from lyophilized mycelia according to Doyle and Doyle (8). Lambda DNA from positive lambda clones was prepared according to Maniatis et al. (21). Plasmid DNA was extracted using Genomed columns following the manufacturer's protocol (Genomed, Bad Oeynhausen, Germany). RNA for Northern blot analysis was isolated by using the RNAgents Total RNA Isolation Kit (Promega, Mannheim, Germany).

Screening of G. fujikuroi cDNA library and genomic lambda EMBL3 library. The expression library (UniZap XR vector; Stratagene) was constructed from RNA isolated from mycelia which were grown under optimal conditions for GA formation (22). Approximately 50,000 recombinant phages were plated at about 7,500 plaques per 150-mm-diameter Petri dish and transferred to nylon membranes. For screening of the genomic library (33), about 35,000 recombinant phages were plated and transferred to membranes. Hybridization was performed at high stringency (65°C). The blots were washed under hybridization conditions (2× SSC [1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 0.1% sodium dodecyl sulfate [SDS]; 65°C; followed by 0.1× SSC, 0.1% SDS). Positive recombinant clones were used for a second round of plaque purification.

Southern and Northern blot analysis. After incubation with restriction endonucleases and electrophoresis, genomic or lambda DNA was transferred to Hybond N⁺ filters (Amersham Pharmacia, Freiburg, Germany) (28). ³²P-labeled probes were prepared using the random oligomer-primer method. Filters were hybridized at 65°C in 5× Denhardt's solution containing 5% dextran sulfate (21). Filters were washed at the hybridization temperature in 2× SSPE (1× SSPE is 0.18 M NaCl, 10 mM NaH₂PO₄, and 1 mM EDTA [pH 7.7]), 0.1% SDS, and 1× SSPE, 0.1% SDS.

Sequence analysis. DNA sequencing of recombinant plasmid clones was accomplished by using a LI-COR 4000 automatic sequencer (MWG, München, Germany). Overlapping subclones of the genomic DNA and the cDNA clones were prepared and both strands were sequenced using the universal and the reverse primers. For identification of the mutation in B1-41a, two additional specific sequencing primers were used: P450-4-M1 (5'-CTATAGGTTTCAGCCACATCC-3') and P450-4-M2 (5'-ATCATCCCGCCAAACTACATCG-3'). Sequence analysis was performed using the Seqman II computer program (DNA STAR Inc., Madison, Wis.).

Transformation of G. fujikuroi. Protoplast preparation and transformation was carried out as previously described (33). For gene disruption, 10⁷ protoplasts (100 µl) of strain IMI 58289 were transformed with 10 µg of the circular gene disruption vector pP450-4-GD. For complementation of the mutant strains B1-41 and SG139 with the intact P450-4 gene, protoplasts were transformed with 10 µg of the circular complementation vector pP450-4-GC.

GA assay. For analysis of GA formation, the wild-type strain and P450-4-disrupted mutants were cultivated in 100-ml Erlenmeyer flasks containing 20 ml of OPM. Cultures were incubated for 7 days on a rotary shaker (200 rpm) at 28°C. GA₃ was analyzed by high-performance liquid chromatography (HPLC) according to Barendse et al. (2) by using a Merck HPLC system with a UV detector and a Lichrispher 100 RP18 column (5 µm; 250 by 4 mm; Merck, Darmstadt, Germany). GA₃, GA₄, and GA₇ also were analyzed by thin-layer chromatography and eluted with ethyl acetate:chloroform:acetic acid (60:40:5). Extracts of culture filtrates and mycelia were analyzed by gas chromatography-mass spectroscopy (GC-MS) as described previously (18).

PCR. G. fujikuroi m567 DNA was used as template for amplification of an internal fragment of the P450-4 gene. The specific primers had the following sequences: P450-4-GD1, 5'-GGTCCAGAGCACTGCCGC-3'; P450-4-GD2, 5'-CTTCCTTTCCCATCTGGC-3'. DNA amplification was performed in 50-µl mixtures using 2 U of Taq DNA polymerase (Red-Taq; Sigma-Aldrich), 50 ng of genomic DNA/µl, 50 µM concentrations of each deoxynucleoside triphosphate, 200 nM concentrations each primer, and 1× Taq buffer containing 15 mM MgCl₂ (Sigma-Aldrich). PCR was carried out for 36 cycles, each comprising 1 min of denaturation at 94°C, 0.5 min of annealing at 56°C, and 1.5 min of extension at 72°C. The PCR product was purified by using a gel extraction kit (Genomed), precipitated with 0.3 M sodium acetate and 2 volumes of ethanol, and cloned using the PCR2.1 vector system (Invitrogen).

Incubations with radiolabeled substrates. Three milliliter aliquots of the fungal cultures, grown in 10% ICI medium (9) for 5 days at 25°C, were transferred to sterile 50-ml Falcon tubes to which 2.5 kBq of ¹⁴C₄-labeled ent-kaurene, ent-kaurenol, ent-kaurenal, or ent-kaurenoic acid were added in methanol (18 to 75 µl). After incubation on an orbital shaker at 25°C for 3 days, the cultures were filtered and the filtrates were adjusted to pH 3 with 1 N HCl and partitioned against ethyl acetate (3 equal volumes), which was taken to dryness under a stream of N₂. The mycelia were extracted with 10 ml of methanol overnight, the extracts were passed through silica gel (500 mg), which was eluted with a further 10 ml of methanol, and the combined eluates were taken to dryness in vacuo. The ethyl acetate extracts were analyzed by reverse-phase HPLC with on-line radioactivity monitoring (19). After loading onto a guard column in solvent A (10% methanol-water containing 50 µl of acetic acid/liter) for 5 min, samples were eluted through an ODS Hypersil column (25 by 0.46 cm) with a linear gradient of 20 to 100% solvent B (methanol containing 50 µ of acetic acid/liter) over 24 min at 1 ml/min, after which the column was eluted with solvent B for a further 5 min. Mycelial extracts were similarly analyzed by HPLC, but by using a gradient of 75 to 100% solvent B over 30 min followed by 30 min with solvent B. The most significant radioactive products were collected, converted to methyl esters and trimethylsilyl ethers, and analyzed by GC-MS (18).

Nucleotide sequence accession number. The nucleotide sequence for the G. fujikuroi P450-4 gene (CYP503) has been deposited in the GenBank/EMBL databases under accession number Y17243 (3,090 bp).

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

Isolation and expression of P450-4. A 5.8-kb BamHI fragment containing part of P450-1 was cloned and shown to contain a 1,574-bp open reading frame transcribed in the opposite orientation to that of P450-1 (Fig. 2A and B). Analysis of sequence databases indicated that the gene encodes a cytochrome P450 monooxygenase and constitutes a novel P450 family, CYP 503. The genomic sequence of this novel cytochrome monooxygenase gene, P450-4, has three introns relative to the sequence of the corresponding cDNA clones from a cDNA library of G. fujikuroi m567.

View larger version (27K): [in this window] [in a new window]   FIG. 2.   The P450-4 gene of G. fujikuroi. (A) Position of the P450-4 gene in the GA biosynthesis gene cluster in G. fujikuroi. (B) Physical map of P450-4. The position of PCR primers is indicated. (C) Strategy for the construction of the disruption vector pP450-4-GD.

View larger version (22K): [in this window] [in a new window]   FIG. 3.   Partial sequence alignment of the highly conserved regions between the four G. fujikuroi P450 monooxygenases involved in GA biosynthesis and three other cytochrome P450 monooxygenases: G.f. P450-1  G. fujikuroi P450-1 (accession number (AC): Y15277); G.f. P450-2  G. fujikuroi P450-2 (AC: Y15278); G.f. P450-3  G. fujikuroi P450-3 (AC: Y15279); G.f. P450-4  G. fujikuroi P450-4 (AC: Y17243); A.t. GA3  ent-kaurene oxidase of Arabidopsis thaliana (AC: AF047719); H.s. P450  human cholesterol 7-monooxygenase (AC: P22680); C.m. P450  alkane-inducible cytochrome P450 monooxygenase of Candida maltosa (AC: JS0726). The presumed heme-binding site of the P450-type enzymes is F--G---C-G.

View larger version (62K): [in this window] [in a new window]   FIG. 4.   Northern blot analysis of the G. fujikuroi P450-4 gene. The mycelium was grown for 15, 24, 38, 48, and 60 h in the GA production medium. As a control for RNA concentration, the blot was hybridized with the ribosomal DNA from G. fujikuroi.

Disruption of P450-4. Following transformation with pP450-4-GD, we analyzed 35 hygromycin B-resistant colonies by Southern blot hybridization. Two of the transformants, T12 and T13, had lost the 5.4-kb XbaI wild-type band but produced two new hybridizing bands of 4.3 and 9.1 kb, predicted after integration of the 7.8-kb vector, pP450-4-GD, into the P450-4 locus (Fig. 5). Neither of the P450-4 mutants produced GAs. The culture medium from the wild type contained mainly GA₃ and smaller amounts of other GAs and ent-kaurenoids, which were absent in the extract from the mutant (Fig. 6A). The mutant mycelia contained ent-kaurene as the only intermediate in the GA biosynthesis pathway (data not shown).

View larger version (26K): [in this window] [in a new window]   FIG. 5.   Southern blot analysis of the wild-type strain IMI 58289 and the disruption mutants P450-4-T12 and T13. The genomic DNA was digested with XbaI and probed with the cDNA fragment of P450-4.

View larger version (38K): [in this window] [in a new window]   FIG. 6.   Characterization of the P450-4-disruption mutant T12. (A) Total ion current traces from GC-MS analysis of culture filtrates of the P450-4-T12 transformant and wild type (IMI 58289). Peaks: 1, GA9; 2, 7-hydroxykaurenolide; 3, GA4; 4, fujenoic acid; 5, GA7; 6, GA13; 7, 7, 18-dihydroxykaurenolide; 8, GA3. The traces are normalized to the largest peak in both traces. (B) HPLC radiochromatograms of extracts of mycelia and culture filtrates (medium) from incubations of ent-[14C]kaurene, ent-[14C]kaurenol, ent-[14C]kaurenal, and ent-[14C]kaurenoic acid with the wild-type (IMI 58289), P450-4-T12, and the mutant, B1-41a. (C) HPLC radiochromatograms of extracts of culture filtrates (medium) from incubations of 14C-labeled GA12 aldehyde, GA14, and GA4 with the wild type and P450-4-T12.

Characterization of the enzymatic function of P450-4. After incubation of ¹⁴C-labeled ent-kaurene, ent-kaurenol, ent-kaurenal, and ent-kaurenoic acid with cultures of T12, only ent-kaurenoic acid was converted efficiently to GA₄ (Fig. 6B). There was no conversion of ent-kaurene or ent-kaurenal; an apparent low-level formation of GA₄ from ent-kaurenol was probably due to a small amount of ent-kaurenoic acid in this substrate. The wild-type strain converted each intermediate to GA₃. The ¹⁴C-labeled intermediates GA₁₂-aldehyde and GA₁₄ were metabolized by P450-4-T12 to GA₄, and [¹⁴C]GA₄ was not converted to GA₃ by this strain (Fig. 6C). All three intermediates were incorporated into GA₃ when incubated with the wild-type strain.

View larger version (43K): [in this window] [in a new window]   FIG. 7.   Characterization of SG139 transformed with the vector pP450-4-GC carrying the complete gene P450-4. (A) Northern blot analysis of SG139 and five complemented transformants. The blot was probed successively with the cDNA fragments of P450-4, cps/ks (control for the deletion), and the Gibberella 18S ribosomal DNA. (B) HPLC radiochromatograms of mycelial extracts from incubations of ent-[14C]kaurene with the wild type (IMI 58289), SG139, and SG139-transformant T10.

Complementation of the UV mutant B1-41a. We transformed B1-41a with the vector pP450-4-GC. Fifty hygromycin-resistant transformants were analyzed for GA formation. Among the transformants, 38 produced wild-type levels of GA₄, GA₇, and GA₃ as detected by thin-layer chromatography. Ten of them were analyzed quantitatively by HPLC. They produced between 250 and 350 mg of GA₃/liter after a cultivation of 8 days in OPM. The wild-type strain produced 320 mg of GA₃/liter under the same conditions. Therefore, the gene P450-4 fully complements the mutation in the mutant strain B1-41a.

Identification of the mutation site in the sequence of the P450-4 mutant allele. A point mutation was found at position 663 of the B1-41a sequence. The last base pair of the 3' splicing consensus sequence AG in intron 2 was replaced by A, presumably resulting in a severe reduction in gene function due to incorrect splicing.

Expression studies with B1-41a. RT-PCR was used to confirm the sequencing results by comparing the P450-4 mRNA for the wild type and B1-41a. The primers are located on the left and the right sides of intron 2 and amplify 551 bp of genomic DNA (Fig. 2). The expected size of 499 bp was obtained from the wild-type cDNA, but the cDNA fragment from the mutant strain was larger (550 bp) than the wild-type genomic fragment, and only a very faint band of the wild-type cDNA was observed (Fig. 8A). The larger mutant cDNA fragment was cloned into the PCR cloning vector, and three independent clones were sequenced. The results confirmed the expected splicing defect, i.e., intron 2 was not removed from the B1-41a mRNA (data not shown).

View larger version (40K): [in this window] [in a new window]   FIG. 8.   Expression of the P450 gene in the wild-type and P450-4 mutant strains. (A) RT-PCR using primers P450-4-RT1 and P450-4-RT2 with the following templates: genomic DNA from wild-type (lane 1), cDNA from wild-type (lane 2), and cDNA from B1-41a (lane 3). Lane 4 contains a 1-kb ladder as marker. (B) Northern blot analysis using the P450-4 and the cps/ks cDNAs as probes on RNA from wild-type and mutant strains.

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

We cloned the P450-4 gene of G. fujikuroi by chromosome walking. The gene is located to the left of P450-1 in the recently-identified GA biosynthesis gene cluster (31) and is transcribed from right to left in the opposite direction to P450-1. The closest related cytochrome P450, the human cholesterol 7-monooxygenase, as well as P450-1, P450-2, and P450-3 of G. fujikuroi, have less than 40% amino acid identity to P450-4; therefore, P450-4 defines a new cytochrome P450 family in accordance with the guidelines for P450 nomenclature (23).

Expression of the gene was high under conditions of GA production, whereas the transcript level is very low in the growth phase, similar to the expression pattern of the other genes of the pathway. Biochemical analysis of transformants with a disrupted P450-4 gene indicated that the gene is responsible for the oxidation of ent-kaurene, an early reaction in the pathway of GA biosynthesis. Incubations with radiolabeled precursors showed that ent-kaurenoic acid, but not earlier precursors, is efficiently metabolized by these transformants, suggesting that the enzyme catalyzes all three oxidative steps from ent-kaurene to ent-kaurenoic acid via ent-kaurenol and ent-kaurenal (Fig. 1). This function was confirmed by demonstrating that the SG139 mutant, which lacks the GA biosynthesis gene cluster and failed to metabolize ent-kaurene, converted ent-kaurene to ent-kaurenoic acid after transformation with the P450-4 gene. P450-4 is the second gene after P450-1 (27) that we have expressed in this deletion mutant to demonstrate the function of the encoded enzyme.

In plants, several GA-deficient dwarf mutants are defective in ent-kaurene oxidase activity. In peas, the mutant lh-2, affected in stem elongation and seed development, is deficient in all three steps from ent-kaurene to ent-kaurenoic acid, also suggesting that a single enzyme catalyzes these reactions (29). Furthermore, the product of the GA3 gene of Arabidopsis, which encodes ent-kaurene oxidase (15), also was shown to catalyze the conversion of ent-kaurene to ent-kaurenoic acid (14). Despite having the same functions in the GA biosynthesis pathway, the amino acid identity between P450-4 in G. fujikuroi and GA3 in Arabidopsis is only 26% over 235 amino acids. Recently, a barley gene and two homologues from Arabidopsis were shown to encode cytochrome P450s that catalyze the three steps of the GA biosynthesis pathway from ent-kaurenoic acid to GA₁₂ (13). The function of these enzymes is, thus, similar to that of P450-1 (GA₁₄ synthase) in G. fujikuroi.

Although ent-kaurenoic acid was metabolized efficiently by the P450-4-disrupted transformant P450-4-T12, it was converted only to GA₄, whereas the wild-type strain and mutant B1-41 a strain converted ent-kaurenoic acid to GA₃. Incubations with later biosynthetic intermediates confirmed that GA₄ was not further metabolized by the transformant. Thus, it appears that at least the gene encoding the enzyme that converts GA₄ to GA₇, a 1,2-desaturase, is not expressed in T12. We showed that the cps/ks (ent-kaurene synthase) gene is expressed less highly in B1-41a and, particularly, in the transformants P450-4-T12 and T13 than in the wild type and may thus be under positive feedback control by a product of the pathway. The gene encoding the desaturase, and possibly also the gene encoding the 13-hydroxylase converting GA₇ to GA₃, may be under similar control. This effect may be due to the specific integration of the disruption vector into the P450-4 locus since all the other transformants with ectopic vector integrations showed a GA₃ production similar to the wild type (data not shown). In contrast to T12, B1-41a, which has a point mutation in the same gene, metabolized ent-kaurenoic acid and GA₄ to GA₃. As discussed below, the mutation in B1-41a is slightly leaky, allowing small amounts of GAs to be produced and, therefore, feedback control of gene expression. An alternative explanation for the reduced expression of cps/ks and other genes in the gene disruption mutants is that the integration of a 7.7-kb DNA fragment of the circular disruption vector, pP450-4-GD, into the P450-4 locus may affect the expression of neighboring genes in the cluster. These possibilities can be investigated once these genes have also been characterized and transformed as single genes into the deletion mutant SG139.

The suggestion that P450-4 encodes ent-kaurene oxidase is supported by the successful complementation of the B1-41a mutant. In most cases, transformation with wild-type P450-4 restored the ability of the mutant, in which GA biosynthesis was reported to be blocked between ent-kaurenal and ent-kaurenoic acid (4), to produce the full spectrum of GAs, including GA₄, GA₇, and GA₃. Although the DNA used for complementation contained most of P450-1 in addition to P450-4, B1-41 already contains a functional P450-1, which converts ent-kaurenoic acid to GA₁₄ (27), as it metabolizes ent-kaurenoic acid normally. The complementation must therefore be due to P450-4. We also transformed the mutant B1-41a with P450-1, P450-2, and P450-3 and analyzed 50 transformants from each complementation, experiment (data not shown). None of these genes complemented the mutation in B1-41a, demonstrating the high substrate specificity of the cytochrome P450 monooxygenases in the GA biosynthesis pathway.

Sequence comparison between the wild-type and mutant copies of P450-4 revealed the mutation in B1-41a to be a single base substitution (GA) at position 663, which removed the 3' consensus sequence of intron 2 preventing, or substantially reducing, correct splicing. This may result in a premature translation stop or possibly splicing at a later 3' acceptor splice site producing a truncated transcript. Indeed, some active enzyme is produced. Our metabolism experiments with B1-41a indicate that it is capable of low rates of conversion of ent-kaurenol and ent-kaurenal, although very little conversion of ent-kaurene was obtained. These results suggest that ent-kaurene oxidation is the rate-limiting reaction in the sequence and is most affected by reduced enzyme activity. The discrepancy between our results and those of Bearder et al. (4) is unexplained.

A similar point mutation to that in B1-41a was detected in the pea ent-copalyl diphosphate synthase (CPS) gene. The ls-1 mutation in this gene results from impaired splicing of the CPS mRNA. RT-PCR experiments revealed three ls-1 mRNAs: ls-1a mRNA from failure of the intron to be removed, ls-1b mRNA from moving the intron-exon boundary one nucleotide towards the 3' end (ag/GA mutated to aaG/A), and ls-1c from using the next possible 3' acceptor splice site (1).

Barrero et al. (3) analyzed the metabolism of GAs in several GA-deficient mutants. They suggested that SG139 was affected in a regulatory gene, as none of the intermediates were converted by this mutant. We demonstrated by Southern blotting, PCR, and Northern blotting that SG139 lacks the entire gene cluster, rendering this strain an excellent system for the expression of single GA pathway genes. Another GA-defective mutant, SG138, was blocked at all three oxidation steps between ent-kaurene and ent-kaurenoic acid but had additional blocks in C-3 and C-13 hydroxylation as well as in the loss of C-20. The authors suggested that the product of the mutated gene in SG138 controls more than one oxidation step in the GA pathway. The fact that SG138 could not convert ent-kaurenoic acid to GA₃ confirmed that this mutant, in contrast to B1-41a and the knockout transformants P450-4-T12 and T13, is blocked at a gene locus other than P450-4, possibly in a P450 reductase gene.

Recently, gene disruption experiments showed that, besides P450-1 and P450-4, the two other monooxygenase genes in the GA gene cluster, P450-2 and P450-3, also are involved in fungal GA biosynthesis, although their functions have not yet been defined (B. Tudzynski and P. Hedden, unpublished). The function of the genes ggs2 (31), cps/ks (31, 32), P450-4 (this paper), and P450-1 (27) have now been determined: they catalyze the steps from farnesyl diphosphate GGPP, from GGPP to ent-kaurene, from ent-kaurene to ent-kaurenoic acid, and from ent-kaurenoic acid to GA₁₄ via GA₁₂-aldehyde, respectively. Although in higher plants monooxygenases and dioxygenases are involved in GA biosynthesis, we have not been able to identify any dioxygenase genes in the GA biosynthesis gene cluster of G. fujikuroi. We are currently examining the function of P450-2 and P450-3 by expression of each gene in the deletion mutant SG139, the results of which should advance considerably our understanding of GA biosynthesis in G. fujikuroi.